This is of paramount importance considering that optimal reporting of RCTs is an important prerequisite for clinical decision-making.
Introduction
Reliable evidence is more likely consequent to sound design and methodology (1, 2) . Among the various study designs the randomized controlled trial (RCT) is considered as the "gold standard" for assessing the effectiveness and safety of medical interventions. Nevertheless, RCTs are also prone to inadequacies and there is a substantial body of evidence in the biomedical literature, which indicates that the quality of many RCTs is suboptimal (3) (4) (5) (6) .
Accurate and transparent reporting of RCTs is prerequisite for the assessment of their internal validity and the clinical translation of their results (7) . In an effort to improve and standardize reporting of RCTs the CONSORT (Consolidated Standards of Reporting Trials) guidelines were developed by the CONSORT group and are continuously being updated. The main CONSORT document consists of 25 items and sets standards on how and what should be included in an RCT report (2) .
The CONSORT guidelines have been endorsed by over 580 journals (8) and there is evidence of a positive impact on RCT reporting (9) . In dentistry reporting quality of RCTs has been assessed in a number of general and dental specialty journals (10) (11) (12) (13) (14) (15) (16) (17) (18) , indicating that there is room for improvement.
However, there is a lack of studies comparatively evaluating the completeness of reporting of recently published RCTs in prosthodontic and implantology using the CONSORT guidelines (2) . terminology in the title or abstract such as "prospective", "comparative", "efficacy" or an indication was given that a comparison of treatment groups was assessed prospectively, were further investigated to examine whether randomization was implemented. Studies that did not involve humans and studies, where it was concluded that no true randomization was implemented, were excluded. Screening and selection of studies were conducted independently by two authors (DK, SNP).
The information extracted from each article included journal and year of publication, region of publication (Europe, Americas or other region, based on the first author), ethical approval, statistical significance of main finding, number of authors, involvement of a statistician or methodologist, and whether the study was single-or multicenter. Involvement of a statistician or methodologist was ascertained by checking author affiliations (public health or epidemiology departments were considered as providing statistical assistance), author degrees (where provided), and information in the methods or acknowledgement sections of each paper.
A modified CONSORT checklist as presented by Tiruvoipati et al. (6) was used to evaluate the reporting completeness of RCTs. This checklist has 30 questions related to the CONSORT items excluding the first item of the CONSORT checklist (title and abstract), since the authors have to follow the instructions of the journal in preparing the abstract. The given score per item ranged from 1 to 3, with 1=no description, 2=inadequate description and 3=adequate description. The scores for the 30 items were added, and a percentage score was calculated for each trial, whereas non-applicable items were not scored. A trial with adequate descriptions (score 3) for all items would receive a score of 90.
All scores were converted to a percentage scale and therefore a score of 90 was equivalent to 100% in the percentage scale. When non-applicable items were identified (for example inability to blind the treatment provider) only the applicable items were considered for the calculation of the percentages.
Therefore, a trial with only 28 applicable items, but adequate descriptions (score 3) for these, would receive a maximum score of 84, corresponding to a percentage of 100%.
Each RCT was also scored using the Jadad scale (19), allocating trials a score between zero (very poor) and five (rigorous). The Jadad scale includes three questions and each one of them is answered with either yes (1 point) or no (no point): (1) "Is the study described as randomized?"; (2) "Is the study described as double blinded?"; (3) "Is there a description of withdrawals and dropouts?". Two additional points, to reach a maximum score of 5, are given (i) if the method of randomization is clearly described and appropriate or (ii) if the method of blinding is clearly described and appropriate. One or F o r P e e r R e v i e w 5 two points are subtracted if the method of randomization or the method of blinding is described, but is inappropriate.
Each included RCT was scored independently by 2 authors (DK, SNP), and subsequently results were compared and modified in order to arrive to a mutually agreed score. Discrepancies between the 2 authors (DK, SNP) were resolved by discussion. Before data extraction, a calibration exercise was performed between the two authors responsible for it (DK, SNP) with 80 randomly selected studies. Inter-rater agreement was evaluated for all extracted data with Cohen's kappa and any disagreements were resolved with discussion.
Statistical Analysis
Descriptive statistics were calculated for the modified CONSORT scores and tabulated by trial characteristics. The modified CONSORT scores were approximately normally distributed. Data were analyzed through linear regression modeling; univariable analysis was utilized to determine articles' characteristics associated with the modified CONSORT scores, whereas multivariable analysis was employed to adjust for possible confounders. A two-tailed P-value of 0.05 was considered statistically significant with a 95% confidence interval. Analyses were performed with the STATA ® version 13.0 software (Stata Corporation, College Station, Texas, USA).
Results
From the 3667 articles that were originally screened 3520 were excluded for not adhering to the inclusion criteria, leaving 147 RCTs for detailed assessment (Appendix 1). Inter-rater agreement was found to be excellent (kappa 0.88, 95% CI: 0.87-0.89). The included RCTs reported on a wide selection of topics ranging from surgical implant procedures and techniques, survival of implants and prostheses, biological responses, clinician's perspective of esthetics and patient satisfaction. Table 4 presents the results of the univariable and multivariable linear regression analyses. In the univariable analysis, the journal of publication and the involvement of a statistician/methodologist were significantly associated with the CONSORT scores. Similar associations were observed in the multivariable analysis. 
Discussion
In this study the reporting quality of RCTs in the fields of prosthodontics and implant dentistry was assessed using a modified CONSORT statement (6) and the Jadad scale (19). The mean modified CONSORT scores ranged from 60.9% to 80.6 % among the journals included in the study, a finding similar to the scores reported in medical journals (6, 20) . The Jadad score ranged from 1.0 to 3.5; this finding is comparable to other fields in medicine (6) . Although all quality score scales have inherent limitations and caution should be used when evaluating reporting quality, the overall score indicates that there is room for improvement.
Pre-study sample size calculation is an important part of designing a trial, and guards against underpowered trials that may result in waste (21) (22) (23) (24) . In the present study 64.0% of the RCTs did not report sample size calculation at all, while, 8.2% of them reported it inadequately. Chan and Altman (25) reported that 73% of the 519 medical trials published in PubMed in December 2000 did not report sample size calculation. It seems that problematic reporting of pre-study sample size calculations in RCTs is a common finding in the literature (11, 14, (26) (27) (28) (29) (30) . Trials with insufficient sample size can be considered unethical, wasteful (21) (22) (23) (24) and less credible compared to trials of sufficient size.
The reporting of the randomization process should, ideally, include details about both the methods used to generate the random allocation sequence and any restrictions used during the process.
Terms such as "patients were randomly assigned" or "two groups were formed at random" are considered inadequate. The current study showed that the generation of the unpredictable allocation sequence was reported inadequately in 11.6% of the cases or not at all in 32.7% of the cases. Altman and Dore (31) studied 80 medical trials published in four leading medical journals and concluded that in 30% of trials there was no clear evidence that the groups had been randomised.
In dentistry, Montenegro et al. (15) found that only 17% of the trials published in periodontal journals reported the randomization process adequately. Koletsi et al. (32) found that from 112 clinical trials in the orthodontic literature labeled as RCTs, only 29.5% were indeed identified as RCTs based on clear descriptions of appropriate random number generation.
Allocation concealment ensures that neither the investigators nor the patients know which treatment the next patient will be allocated to and guards against confounding. Although allocation concealment is always feasible, the results showed that 61.9% of the included RCTs did not report allocation concealment at all, while 17.7% of them reported it inadequately. These results are in accordance with previous studies; Pandis et al . (18) reported 22% adequacy in reporting allocation Another key element in RCT reporting is the description of blinding. Blinding is important to the validity of a trial, as it prevents performance and detection bias, and protects the sequence after allocation. Often the concepts of allocation concealment and blinding are confused. Blinding is especially important for subjective outcomes (e.g. pain scores), as these are more prone to bias.
Blinding of the patients and the treatment providers may not always be possible, however, blinding of the assessors and the analysts is (33, 34 Statistical methods used for data analysis were not described in 6.1% whereas 59.2% of the RCT reports provided an adequate description. These results are similar to a previous assessment in dentistry, which reported that 3% of the studies provided no description and 51% provided adequate description of statistical methods (18) . Analyses should be pre-specified and ideally described in the trial protocol. Pre-specification allows for the assessment of selective reporting and data driven analysis which can be misleading. A common statistical pitfall is the conduct of multiple tests, which leads to increased type I error (false positive) that can be misleading when associated with selective reporting. It is recommended that subgroup analyses should be pre-specified and kept to the minimum (35, 36) . The results of the present study showed that 30.6% of the trials did not describe how this issue was handled, while 34.0% of the reports described it adequately. Pocock et al. (37) studied 45 medical trials published in three high impact factor medical journals and they reported that multiple endpoints were analyzed without being pre-specified as primary endpoints.
Finally, in the present study 6.1% and 80.2% of the trials lacked complete description of estimates and confidence intervals, respectively. Previous studies found inadequate results' reporting in leading medical journals (37). Pandis et al. (18) found that dental trials also suffered from problematic reporting in this area of interest, with lack of description in 3% and 80% of the studied trials and adequate description in 62% and 20% of them for the complete reporting of the results and for the reporting of confidence intervals respectively. Reporting of estimates and confidence intervals facilitates interpretation in relation to clinical importance. P-values and statistical significance are based on arbitrary cut-off points (i.e. 0.05) and are sensitive to sample size and variance. Small P- This study is not free of limitations. A limitation might be that the scoring of trials is always susceptible to some degree of subjectivity. Nevertheless, considerable efforts were made to compensate for inter-rater subjectivity by calibration exercises before study commencement and strict adherence to applied CONSORT guidelines. RCT assessment was limited to high impact factor prosthetic journals and therefore published RCTs in lower impact factor journals or even nonpublished RCTs were excluded. However, we believe that the selected journals constitute a representative or best case scenario sample of the reporting status in the specialty. It should be, also, underlined that incomplete reporting of trials does not necessarily infer low quality of conducting or false methodology (39) . Researchers might have designed and conducted a study ideally, but they might have omitted reporting accurately all stages and aspects of their trial due to, for instance, space limitations. Even though RCTs are pivotal for evidence-based dentistry and medicine, they are not free of shortcomings. It is important that they are designed properly, implemented and reported well.
Numerous journals have adopted the CONSORT guidelines and very few have implemented active compliance. The American Journal of Orthodontics and Dentofacial Ortopedics, for instance, has recently implemented a novel approach which includes assessment of compliance at the editorial level and specific recommendations for the authors in order to improve RCT reporting. A preliminary study indicated that this approach has increased dramatically reporting quality (40) . In addition the journal has recently adopted a structured report which diverges from the standard IMRaD 
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